Rugo HS - Search Results

1

High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA. Smith GA, et al. Among authors: rugo hs. J Clin Oncol. 1997 Feb;15(2):833-9. doi: 10.1200/JCO.1997.15.2.833. J Clin Oncol. 1997. PMID: 9053511

2

Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital.

O'Hanley P, Easaw J, Rugo H, Easaw S. O'Hanley P, et al. Am J Med. 1989 Dec;87(6):605-13. doi: 10.1016/s0002-9343(89)80391-2. Am J Med. 1989. PMID: 2589395

3

High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.

Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA. Rugo HS, et al. Prog Clin Biol Res. 1994;389:505-11. Prog Clin Biol Res. 1994. PMID: 7535460 No abstract available.

4

Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.

Damon LE, Rugo HS, Ries CA, Linker CA. Damon LE, et al. Among authors: rugo hs. Leukemia. 1994 Apr;8(4):535-41. Leukemia. 1994. PMID: 8152248

5

Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.

Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL. Linker CA, et al. Among authors: rugo hs. Semin Oncol. 1993 Aug;20(4 Suppl 4):40-8; quiz 49. Semin Oncol. 1993. PMID: 8342075

6

Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.

Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Linker CA, et al. Among authors: rugo hs. Blood. 1993 Jan 15;81(2):311-8. Blood. 1993. PMID: 8422457 Free article.

7

Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.

Damon LE, Rugo HS, Ries CA, Linker CA. Damon LE, et al. Among authors: rugo hs. Bone Marrow Transplant. 1996 Jan;17(1):93-9. Bone Marrow Transplant. 1996. PMID: 8673063

8

The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation.

Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW. Terdiman JP, et al. Among authors: rugo hs. Endoscopy. 1996 Oct;28(8):680-5. doi: 10.1055/s-2007-1005576. Endoscopy. 1996. PMID: 8934085

9

A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia.

Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC Jr, Beer M, Ahmed T. Feldman EJ, et al. Leukemia. 1997 Apr;11(4):485-9. doi: 10.1038/sj.leu.2400623. Leukemia. 1997. PMID: 9096687 Clinical Trial.

10

Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.

Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL. Linker CA, et al. Among authors: rugo hs. Bone Marrow Transplant. 1998 Nov;22(9):865-72. doi: 10.1038/sj.bmt.1701436. Bone Marrow Transplant. 1998. PMID: 9827814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters